Julie Baker
Corporate Officer/Principal bei LONGBOARD PHARMACEUTICALS, INC.
Profil
Julie Baker is currently the Vice President-Commercial Strategy at Longboard Pharmaceuticals, Inc. Prior to this, she was the Vice President-Marketing at Jazz Pharmaceuticals, Inc. from 2021 to 2022 and at Greenwich Biosciences, Inc. from 2020 to 2021.
Ms. Baker completed her undergraduate degree at George Washington University and earned an MBA from New York University.
Aktive Positionen von Julie Baker
| Unternehmen | Position | Beginn |
|---|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2023 |
Ehemalige bekannte Positionen von Julie Baker
| Unternehmen | Position | Ende |
|---|---|---|
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Vertrieb & Marketing | 01.07.2022 |
Greenwich Biosciences, Inc.
 Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA. | Vertrieb & Marketing | 01.11.2021 |
Ausbildung von Julie Baker
| George Washington University | Undergraduate Degree |
| New York University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Greenwich Biosciences, Inc.
Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA. | Health Technology |
